Global Attention Deficit Hyperactivity Disorder (ADHD) Market, By Drug Type (Stimulants and Non-stimulants), by Age Group (Pediatric, Adolescent, and Adult), Distribution Channel (Specialty Clinics, Hospital Pharmacies, Retail Pharmacies, and E-commerce), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Attention-Deficit Hyperactivity Disorder (ADHD) Market
The attention-deficit hyperactivity disorder (ADHD) market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 9.27% in the forecast period of 2021 to 2028. The increase of the patient pool with positive ADHD symptoms will help in escalating the growth of the attention-deficit hyperactivity disorder (ADHD) market.
Attention-deficit hyperactivity disorder is known as a brain disorder in which the patient is hyperactive, impulsive and has absence of attention. The reason for this disorder is not yet identified but it is anticipated that a several factors such as genes, pre-natal brain injuries, exposure of toxins so forth are responsible for ADHD.
Factors such as the upsurge on emphasis and advancements in medical field to advance advanced products for ADHD and the growth in responsiveness about mental illness amongst people are the factors expected to boost the growth of the attention-deficit hyperactivity disorder (ADHD) market in the forecast period. However, the stringent administration and governing procedures and the growth in the price of the medication and the inadequate accessibility of non-stimulants ADHD drugs are the factors most likely to hamper the growth of the attention-deficit hyperactivity disorder (ADHD) market in the coming years. Moreover, contraindications and side-effects linked with ADHD drugs are fettering the quality of life of patients, which is anticipated to further impede the growth of the attention-deficit hyperactivity disorder (ADHD) market in the near future.
This attention-deficit hyperactivity disorder (ADHD) market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on attention-deficit hyperactivity disorder (ADHD) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Attention-Deficit Hyperactivity Disorder (ADHD) Market Scope and Market Size
The attention-deficit hyperactivity disorder (ADHD) market is segmented on the basis of drug type, age group and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on the drug type, the attention-deficit hyperactivity disorder (ADHD) market is segmented into stimulants and non-stimulants. Stimulants is sub segmented into amphetamine, methylphenidate, dextroamphetamine, dexmethylphenidate, and lisdexamfetamine dimesylate. Non-stimulants is sub segmented into atomoxetine, bupropion, guanfacine, and clonidine.
- Based on the age group, the attention-deficit hyperactivity disorder (ADHD) market is segmented into pediatric and adolescent, and adult.
- Based on the distribution channel, the attention-deficit hyperactivity disorder (ADHD) market is segmented into specialty clinics, hospital pharmacies, retail pharmacies, and e-commerce.
Attention-Deficit Hyperactivity Disorder (ADHD) Market Country Level Analysis
The healthcare analytical testing services market is analysed and market size insights and trends are provided by country, drug type, age group and distribution channel as referenced above.
The countries covered in the attention-deficit hyperactivity disorder (ADHD) market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the attention-deficit hyperactivity disorder (ADHD) market because of the large volume of drug prescriptions every year and the growing of the product launches. Furthermore, the growth in the collaboration amongst the players to improve the market penetration and for the product expansion which in turn will further boost the growth of the attention-deficit hyperactivity disorder (ADHD) market in the region during the forecast period. Europe is projected to observe significant amount of growth in the attention-deficit hyperactivity disorder (ADHD) market because of the growing alertness about the mental health and the increasing of the incidences of attention-deficit or hyperactivity disorder. Furthermore, the high ingestion of additives and preservatives, and the improvising of the coverage for treatment of the condition which in turn are anticipated to further propel the growth of the attention-deficit hyperactivity disorder (ADHD) market in the region in the coming years.
The country section of the attention-deficit hyperactivity disorder (ADHD) market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The attention-deficit hyperactivity disorder (ADHD) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for healthcare analytical testing services market, impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the attention-deficit hyperactivity disorder (ADHD) market. The data is available for historic period 2010-2019.
Competitive Landscape and Attention-Deficit Hyperactivity Disorder (ADHD) Market Share Analysis
The attention-deficit hyperactivity disorder (ADHD) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to attention-deficit hyperactivity disorder (ADHD) market.
The major players covered in the attention-deficit hyperactivity disorder (ADHD) market report are Takeda Pharmaceutical Company Limited, Neos Therapeutics, Inc., Lilly, Pfizer Inc., Alcobra Ltd., Supernus Pharmaceuticals, Inc., Noven Pharmaceuticals, Inc., Novartis AG, Johnson & Johnson, Curemark, LLC., MonoSol Rx, KemPharm, Inc., Neurosigma, Inc., Impax Laboratories, LLC, Hisamitsu Pharmaceutical Co.,Inc., Mallinckrodt, UCB S.A., Purdue Pharma L.P., Johnson & Johnson Services, Inc., Actavis, among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-
